Monitoring lamivudine therapy in HBV-infected patients by the quantity and structures of circulating viral nucleic acids
|Updated:2026-03-12
|
Monitoring lamivudine therapy in HBV-infected patients by the quantity and structures of circulating viral nucleic acids
Military Medical ResearchIssue 3, Pages: 2-174(2003)
Affiliations:
1. Department of Pathology
2. Tangdu Hospital
3. Fourth Military Medical University
4. ,Germany
5. Department of Virus-Host Interactions
6. Deutsches Krebsforschungszentrum Heidelberg
Author bio:
Funds:
DOI:
CLC:R512.6
Published:2003
Accepted:
Scan QR Code
[1]张伟,Hans Jrg Hacker,Maria Mildenberger,Claus H.Schrder,苏勤.Monitoring lamivudine therapy in HBV-infected patients by the quantity and structures of circulating viral nucleic acids[J].Journal of Medical Colleges of PLA,2003(03):2-174.
DOI:
[1]张伟,Hans Jrg Hacker,Maria Mildenberger,Claus H.Schrder,苏勤.Monitoring lamivudine therapy in HBV-infected patients by the quantity and structures of circulating viral nucleic acids[J].Journal of Medical Colleges of PLA,2003(03):2-174.DOI:
Monitoring lamivudine therapy in HBV-infected patients by the quantity and structures of circulating viral nucleic acids
摘要
Abstract
<正> To monitor the progression of lamivudine therapy by demonstrating HBV DNAs and RNAs in the serum of achronically infected patient. Viral nucleic acids were exracted from serum samples taken during a 14-week treatmentperiod and analyzed via competitive PCR and RT/PCR. The dynamic changes in the amount as well as in the structurescan monitor therapy process very well. Our study indicated the level of polyadenylated viral RNA can be a marker forexpression in general
and the appearance of replicative intermediates as a mirror of the mode of action of an antiviraldrug.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.